NeuroFlow, a Philadelphia, PA-based provider of a behavioral health SaaS platform, received an investment from Concord Health Plans.
The amount of the deal was not disclosed.
The company intends to use the funds to continue to expand operations, and its business reach within the complex payor and government agency segments.
Led by CEO Chris Molaro, NeuroFlow provides a platform that combines AI-driven analytics, care collaboration enablement, and enterprise consumer grade activation to reduce the risks of identifying, managing, and monitoring complex behavioral health and substance use populations. Customers are empowered to integrate behavioral health across populations, and by doing so reduce the risks associated with undiagnosed and misdiagnosed behavioral health conditions. The platform takes this population intelligence and makes it actionable for providers and care managers by integrating it into the delivery workflow and providing evidence-based decision support to ensure appropriate care. Consumers are engaged through the integrated workflow, which improves consumer adherence to treatment and provides a safety net of capabilities in between clinical and non-clinical interactions.
FinSMEs
07/09/2023